Title (en)

USE OF DELTA5-ANDROSTENE-3BETA-OL-7,17-DIONE IN THE TREATMENT OF ARTHRITIS

Title (de)

VERWENDUNG VON DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN DER BEHANDLUNG DER ARTHRITIS

Title (fr)

UTILISATION DE DELTA5-ANDROSTENE-3BETA-OL-7,17-DIONE DANS LE TRAITEMENT DE L'ARTHRITE

Publication

EP 1032266 A1 20000906 (EN)

Application

EP 98958020 A 19981117

Priority

• US 9824458 W 19981117
• US 6619797 P 19971119

Abstract (en)

[origin: WO9925192A1] Arthritis can be treated by administering therapeutic amounts of DELTA 5-androstene-3 beta -ol-7,17-dione and metabolizable precursors thereof, such as DELTA 5-androstene-3 beta -acetoxy-7,17-dione, which are readily metabolized in vivo to DELTA 5-androstene-3 beta -ol-7,17-dione but are not appreciably metabolizable in vivo to androgens, estrogens or dehydroepiandrosterone. Such treatment can be prophylactic, ameliorative or curative in nature.

[origin: WO9925192A1] Arthritis can be treated by administering therapeutic amounts of DELTA 5-androstene-3 beta -ol-7,17-dione and metabolizable precursors thereof, such as DELTA 5-androstene-3 beta -acetoxy-7,17-dione, which are readily metabolized in vivo to DELTA 5-androstene-3 beta -ol-7,17-dione but are not appreciably metabolizable in vivo to androgens, estrogens or dehydroepiandrosterone. Such treatment can be prophylactic, ameliorative or curative in nature.

IPC 1-7

A01N 45/00; A61K 31/56

IPC 8 full level

A61K 31/565 (2006.01)

CPC (source: EP)

A61K 31/565 (2013.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9925192 A1 19990527; AU 1414299 A 19990607; AU 766908 B2 20031023; CA 2311471 A1 19990527; EP 1032266 A1 20000906; EP 1032266 A4 20030716

DOCDB simple family (application)

US 9824458 W 19981117; AU 1414299 A 19981117; CA 2311471 A 19981117; EP 98958020 A 19981117